Gene · 7012
Papers4,156
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,156
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lung cancer is also a hereditary disease. | Eur Respir Rev | 2021 | 34670806 | PubTator, text mining | PubMed |
| Differential expression of long non-coding RNAs as diagnostic markers for lung cancer and other malignant tumors. | Aging (Albany NY) | 2021 | 34670194 | PubTator, text mining | PubMed |
| Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: racial, ethnic, and geographical considerations. | Expert Rev Mol Diagn | 2021 | 34666586 | PubTator, text mining | PubMed |
| Profile of esophageal squamous cell carcinoma mutations in Brazilian patients. | Sci Rep | 2021 | 34663841 | PubTator, text mining | PubMed |
| Germline mutations among Polish patients with acute myeloid leukemia. | Hered Cancer Clin Pract | 2021 | 34641967 | PubTator, text mining | PubMed |
| Genomic Changes Driven by Radiation-Induced DNA Damage and Microgravity in Human Cells. | Int J Mol Sci | 2021 | 34638848 | PubTator, text mining | PubMed |
| Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma. | Cancers (Basel) | 2021 | 34638246 | PubTator, text mining | PubMed |
| Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics. | Aging (Albany NY) | 2021 | 34633987 | PubTator, text mining | PubMed |
| Proceedings of the 9th International Symposium on MDS and SAA in Childhood : Athens, Greece. 30 September-2 October 2021. | Mol Cell Pediatr | 2021 | 34633564 | PubTator, text mining | PubMed |
| The Extent of Inflammatory Cell Infiltrate and Fibrosis in Lungs of Telomere- and Surfactant-Related Familial Pulmonary Fibrosis. | Front Med (Lausanne) | 2021 | 34631753 | PubTator, text mining | PubMed |
| Cycloastragenol and Astragaloside IV activate telomerase and protect nucleus pulposus cells against high glucose-induced senescence and apoptosis. | Exp Ther Med | 2021 | 34630680 | PubTator, text mining | PubMed |
| Structural biology of human telomerase: progress and prospects. | Biochem Soc Trans | 2021 | 34623385 | PubTator, text mining | PubMed |
| A chemical probe based on the PreQ1 metabolite enables transcriptome-wide mapping of binding sites. | Nat Commun | 2021 | 34615874 | PubTator, text mining | PubMed |
| Polygenic basis and biomedical consequences of telomere length variation. | Nat Genet | 2021 | 34611362 | PubTator, text mining | PubMed |
| Dysregulated non-coding telomerase RNA component and associated exonuclease XRN1 in leucocytes from women developing preeclampsia-possible link to enhanced senescence. | Sci Rep | 2021 | 34611223 | PubTator, text mining | PubMed |
| Increased telomerase activity in major depressive disorder with melancholic features: Possible role of pro-inflammatory cytokines and the brain-derived neurotrophic factor. | Brain Behav Immun Health | 2021 | 34589765 | PubTator, text mining | PubMed |
| Loss of Growth Differentiation Factor 11 Shortens Telomere Length by Downregulating Telomerase Activity. | Front Physiol | 2021 | 34588995 | PubTator, text mining | PubMed |
| Alternative lengthening of telomeres is mechanistically linked to potential therapeutic vulnerability in the stem-like subtype of gastric cancer. | Clin Transl Med | 2021 | 34586731 | PubTator, text mining | PubMed |
| Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease. | Int J Mol Sci | 2021 | 34576030 | PubTator, text mining | PubMed |
| Endometrial SUSD2+ Mesenchymal Stem/Stromal Cells in Tissue Engineering: Advances in Novel Cellular Constructs for Pelvic Organ Prolapse. | J Pers Med | 2021 | 34575617 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7012/papers?page=48